North America

CD&R acquires wound specialist for $910m

<p><span lang="EN-GB">The investment in Healogics comes from CD&R’s $6.4bn </span><span>Fund IX.</span> </p> <p><span></span> </p>

Northleaf closes debut secondaries fund on $255m

<p>The Toronto-based firm surpassed its $200m target.</p> <p> </p> <p> </p>

Study: PE warms up to restaurant sector

<p>Private equity fund managers and direct investing LPs are increasingly targeting US restaurant chains.</p>

Genstar hires IR exec from CapDyn

<p><span>The San Francisco-based mid-market firm has created a new investor relations position.</span> </p> <p><span></span> </p>

IVP raises $510m for co-investments

<p>Insight Venture Partners’ third co-invest fund will invest alongside IVP’s $2.57bn Fund VIII.</p> <p> </p>

Oak Hill in $1.47bn exit to CCMP

<p>CCMP’s acquisition of the Hillman Companies comes as the firm seeks $3.5bn for its third buyout fund.</p> <p> </p>

Madison Dearborn seals 5x software exit(2)

<p>The Chicago-based firm has sold cloud-based technology company Fieldglass, which it bought for $150m in 2010.</p>

Golden Gate gobbles up Red Lobster for $2.1bn

<p>The San Francisco-based firm will buy the seafood restaurant chain from Darden Restaurants.</p>

Spectrum deal takes Fund VI to 80% invested

<p><span lang="EN-US">The firm’s C$60m investment in Verafin marks the largest growth equity deal in Canada this year.</span> </p>

SEC exam findings a “wake-up call,” says LP

Early investor reaction to the first wave of private equity examinations from the U.S. Securities and Exchange Commission ranges from skepticism, frustration that sponsors don’t provide as much information as investors ask for, to gratitude that the SEC is going to help improve behavior.